Alniditan
Alniditan
Alniditan (pronounced: al-ni-di-tan) is a pharmaceutical drug used in the treatment of migraine.
Etymology
The term "Alniditan" is derived from the chemical name of the drug, which is 3-(1-methyl-1H-indol-3-yl)-N-[2-(1-methyl-1H-indol-3-yl)ethyl]propanamide.
Usage
Alniditan is primarily used in the treatment of acute migraine attacks. It belongs to the class of drugs known as 5-HT1 receptor agonists, or "triptans". These drugs work by constricting blood vessels in the brain that are involved in causing migraine headaches.
Related Terms
- 5-HT1 receptor agonists: A class of drugs that includes Alniditan. These drugs are used to treat migraines by constricting blood vessels in the brain.
- Migraine: A neurological condition characterized by severe, recurring headaches, often accompanied by nausea, vomiting, and sensitivity to light and sound.
- Pharmaceutical drug: A chemical substance used to treat, cure, prevent, or diagnose a disease or to promote well-being.
See Also
External links
- Medical encyclopedia article on Alniditan
- Wikipedia's article - Alniditan
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski